Transient elastography with controlled attenuation parameter for the diagnosis of colorectal polyps in patients with nonalcoholic fatty liver disease

  • 0Department of Gastroenterology, Beijing Chuiyangliu Hospital, Beijing 100022, China.

|

|

Summary

This summary is machine-generated.

High triglyceride (TG) and liver-controlled attenuation parameters (liver-CAP) levels are linked to colorectal polyps in nonalcoholic fatty liver disease (NAFLD) patients. Liver-CAP alone can effectively diagnose NAFLD with colorectal polyps.

Area Of Science

  • Hepatology
  • Gastroenterology
  • Metabolic Syndrome

Background

  • Nonalcoholic fatty liver disease (NAFLD) severity and lipid metabolism are associated with colorectal polyp development.
  • Liver-controlled attenuation parameters (liver-CAPs) are established predictors for hepatic steatosis prognosis.

Purpose Of The Study

  • To identify risk factors for colorectal polyps in NAFLD patients.
  • To analyze liver-CAPs and develop a diagnostic model for colorectal polyps in NAFLD.

Main Methods

  • Case-control study comparing patients with and without colorectal polyps (June 2021-April 2022).
  • Analysis of triglyceride (TG) and liver-CAP levels.
  • Receiver operating characteristic (ROC) curve analysis for diagnostic efficiency.

Main Results

  • Patients with colorectal polyps had significantly higher median TG (1.74 vs 1.05 mmol/L) and liver-CAP (282 vs 254 dB/m) than controls (P < 0.05).
  • TG and liver-CAP were independent risk factors for colorectal polyps (ORs 2.338 and 1.019, respectively; P < 0.05).
  • Liver-CAP alone demonstrated diagnostic efficacy comparable to TG combined with liver-CAP (TG+CAP) (P > 0.05). A liver-CAP > 291 dB/m indicated higher polyp likelihood.

Conclusions

  • Elevated TG and liver-CAP levels are significantly associated with colorectal polyps in NAFLD patients.
  • Liver-CAP is a viable standalone diagnostic marker for NAFLD with colorectal polyps.